Tag: IN.PACT AV Access
Long-term IN.PACT AV data show there is “definitely a place” for...
Matteo Tozzi (Varese, Italy) and Kate Steiner (Stevenage, UK) sat down with Vascular News at this year’s Charing Cross (CX) International Symposium (23–25 April,...
Five-year data finds for IN.PACT AV DCB over plain balloon angioplasty
During the Vascular Access Masterclass session examining the question ‘We have new technology, but do we need it?’ at this year’s Charing Cross (CX)...
“We know which DCB to use”—but many other questions remain in...
A first-time presentation of five-year data from the IN.PACT AV Access study evaluating the IN.PACT AV (Medtronic) drug-coated balloon (DCB) today led principal investigator...
CX 2023: IN.PACT AV three-year subanalysis trial data show “durable” long-term...
The vascular access masterclass session on Tuesday saw a first-to-podium presentation by Andrew Holden (Auckland City Hospital, Auckland, New Zealand) in which he presented...
Experts react to “compelling” 36-month IN.PACT AV Access trial data
NOTE: This video is ONLY available to watch in selected countries and geographies
Robert Shahverdyan (Hamburg, Germany), Matteo Tozzi (Varese, Italy), Alexandros Mallios (Paris,...
Roundtable: Will latest IN.PACT AV Access data impact practice and can...
NOTE: This video is ONLY available to watch in selected countries and geographies
In this Renal Interventions roundtable, Andrew Holden (moderator; Auckland, New Zealand) is...
History warns us against “optimistic exuberance” in drug-coated balloon trials
The importance of assessing clinical trial data in an objective, balanced way has been borne out by recent history in the vascular surgery space,...
First time data release: View the full IN.PACT AV Access trial...
NOTE: This video is ONLY available to watch in selected countries and geographies
In a late-breaking Podium 1st presentation at the 2022 Charing Cross...
Plain balloon first and drug-eluting balloon second? The role of DCBs...
Kate Steiner (Stevenage, UK) discusses existing clinical evidence on drug-coated balloons (DCBs) in the treatment of arteriovenous access stenosis—and outlines areas where further data...
IN.PACT AV DCB sustained “superior” effectiveness in subgroups with high reintervention...
Several subgroups of patients treated with the IN.PACT AV drug-coated balloon (DCB; Medtronic) for arteriovenous fistulas (AVFs) demonstrated a “statistically significant” higher rate of...
More mixed results for DCBs in AV access maintenance as evidence...
Additional randomised controlled data regarding the effectiveness of drug-coated balloons (DCBs) in maintaining arteriovenous (AV) access offers new evidence, but it is freighted with...
Two-year IN.PACT AV Access results presented at CX 2021
Medtronic recently announced the safety and effectiveness results through 24 months for the IN.PACT AV Access clinical study. The data, which were presented virtually...
LINC 2021: Positive first-time data presented for IN.PACT AV DCB and...
New data presented for the first time at LINC 2021 (The Leipzig Interventional Course; 25–29 January, online) support the use of drug-coated balloons (DCBs)...